BioSeek, LLC. Release: BioMAP® Profiling Provides Insights into Toxicity of Nanomaterials, Failed Drugs and Environmental Chemicals
3/12/2012 9:11:27 AM
SAN FRANCISCO--(BUSINESS WIRE)--Assessments of the biological activity of various nanomaterials and chemicals in the context of primary human cell biology were presented today at the annual meeting of the Society of Toxicology by scientists from the U.S. Environmental Protection Agency and BioSeek, LLC. The presented findings further demonstrate the value of BioMAP® human primary cell assay systems for both identifying critical bioactivities and potentially adverse effects of drugs, new materials and other compounds in a high-throughput format.